pf-04965842
Small moleculeexperimental
Clinical trial activity
24 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
16
Phase 2
8
Phase 3
5
Phase 4
0
Earliest trial started May 1, 2013 (NCT01835197)
Timeline
Indications
Studied for
- Dermatitis · Phase 3
- Dermatitis, Atopic · Phase 3
- Eczema · Phase 3
- Genetic Diseases, Inborn · Phase 3
- Healthy Volunteers · Phase 1
- Hypersensitivity · Phase 3
- Hypersensitivity, Immediate · Phase 3
- Immune System Diseases · Phase 3
- Kidney Failure, Chronic · Phase 1
- Liver Diseases · Phase 1
- Psoriasis · Phase 2
- Skin Diseases · Phase 3
- Skin Diseases, Eczematous · Phase 3
- Skin Diseases, Genetic · Phase 3
Mechanism of action
- Tyrosine-protein kinase JAK1INHIBITOR
JAK1 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3544929 ↗
Also known as
- pf-04965842
- pf-04965842
- pf-04965842
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04099563 | Phase 1 | Sep 23, 2019 | Pfizer |
| NCT03915496 | Phase 2 | Aug 31, 2019 | Pfizer |
| NCT04065633 | Phase 1 | Jul 18, 2019 | Pfizer |
| NCT03937258 | Phase 1 | May 21, 2019 | Pfizer |
| NCT03796676 | Phase 3 | Feb 18, 2019 | Pfizer |
| NCT03806101 | Phase 1 | Jan 23, 2019 | Pfizer |
| NCT03796182 | Phase 1 | Jan 10, 2019 | Pfizer |
| NCT03742336 | Phase 1 | Nov 21, 2018 | Pfizer |
| NCT03720470 | Phase 3 | Oct 29, 2018 | Pfizer |
| NCT03660241 | Phase 1 | Oct 11, 2018 | Pfizer |
| NCT03634345 | Phase 1 | Sep 30, 2018 | Pfizer |
| NCT03626415 | Phase 1 | Sep 30, 2018 | Pfizer |
| NCT03662516 | Phase 1 | Sep 26, 2018 | Pfizer |
| NCT03637790 | Phase 1 | Sep 13, 2018 | Pfizer |
| NCT03647670 | Phase 1 | Jul 3, 2018 | Pfizer |
| NCT03386279 | Phase 1 | Jul 2, 2018 | Pfizer |
| NCT03575871 | Phase 3 | Jun 29, 2018 | Pfizer |
| NCT03627767 | Phase 3 | Jun 11, 2018 | Pfizer |
| NCT03349060 | Phase 3 | Dec 7, 2017 | Pfizer |
| NCT03250039 | Phase 1 | Jul 10, 2017 | Pfizer |
Showing 20 of 24 trials
Page 1 / 2
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 24 | 24 | 3 | 2013 |
1 organizations
Page 1 / 1